Literature DB >> 2152991

Interactions between cellular regulatory proteins and a unique sequence region in the human cytomegalovirus major immediate-early promoter.

P Ghazal1, H Lubon, C Reynolds-Kohler, L Hennighausen, J A Nelson.   

Abstract

Transcription from the human cytomegalovirus major immediate-early promoter is dependent on host-cell regulatory proteins. The interactions between cellular nuclear proteins and a unique sequence located from nucleotide position -660 to -540 was investigated. The unique region presents a defined target for multiple distinct DNA-binding proteins which appear, in part, to have overlapping binding sites. A minimum of five sequence-specific DNA-binding activities that interact with sequences between -632 and -602, -602 and -557, -602 and -590, -563 and -540, and -602 and -582 were detected. Evidence is presented to suggest that the -632 to -602 site, a previously characterized nuclear factor 1 binding site, does not bind NF1 but strongly interacts with a distinct cellular factor. The binding of cellular proteins to the unique sequence region was shown to be important in directing transcription from the major immediate-early promoter.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2152991     DOI: 10.1016/0042-6822(90)90049-w

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  A strong negative transcriptional regulatory region between the human cytomegalovirus UL127 gene and the major immediate-early enhancer.

Authors:  C A Lundquist; J L Meier; M F Stinski
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Identification of a boundary domain adjacent to the potent human cytomegalovirus enhancer that represses transcription of the divergent UL127 promoter.

Authors:  A Angulo; D Kerry; H Huang; E M Borst; A Razinsky; J Wu; U Hobom; M Messerle; P Ghazal
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Formation of several specific nucleoprotein complexes on the human cytomegalovirus immediate early enhancer.

Authors:  H H Niller; L Hennighausen
Journal:  Nucleic Acids Res       Date:  1991-07-11       Impact factor: 16.971

Review 4.  Role of the cytomegalovirus major immediate early enhancer in acute infection and reactivation from latency.

Authors:  Mark F Stinski; Hiroki Isomura
Journal:  Med Microbiol Immunol       Date:  2007-12-19       Impact factor: 3.402

5.  Enhancement of RNA polymerase II initiation complexes by a novel DNA control domain downstream from the cap site of the cytomegalovirus major immediate-early promoter.

Authors:  P Ghazal; J A Nelson
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

6.  Functional interaction between the pp71 protein of human cytomegalovirus and the PML-interacting protein human Daxx.

Authors:  Heike Hofmann; Hilde Sindre; Thomas Stamminger
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

7.  Cellular repressor inhibits human cytomegalovirus transcription from the UL127 promoter.

Authors:  Philip E Lashmit; Christopher A Lundquist; Jeffery L Meier; Mark F Stinski
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  Analysis of proteins binding to the proximal promoter region of the human cytomegalovirus IE-1/2 enhancer/promoter reveals both consensus and aberrant recognition sequences for transcription factors Sp1 and CREB.

Authors:  D Lang; H Fickenscher; T Stamminger
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

9.  The 21bp repeat element of the human cytomegalovirus major immediate early enhancer is a negative regulator of gene expression in undifferentiated cells.

Authors:  S Kothari; J Baillie; J G Sissons; J H Sinclair
Journal:  Nucleic Acids Res       Date:  1991-04-25       Impact factor: 16.971

10.  Cytomegalovirus-mediated induction of antisense mRNA expression to UL44 inhibits virus replication in an astrocytoma cell line: identification of an essential gene.

Authors:  A Ripalti; M C Boccuni; F Campanini; M P Landini
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.